Discovery of pan-EphB tyrosine kinase inhibitor for metabolic syndrome sparing EphB3 signaling in mice

The global prevalence of metabolic syndrome had created one of the most pressing public health dilemmas and significant financial burden to the healthcare system. Despite the surge of glucagon-like peptide-1 agonists, recent studies showed that 40 % of body weight loss is due to lean mass loss, rais...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Syed Tareq, Heba A. Ewida, Sumaih Zoubi, Harrison Benson, Dhavalkumar Patel, Hanin Diab, Souvik Patra, Daniela Redrovan, Ehsan Nozohouri, Taysa Berivan Bassani, Alisson Campos Cardoso, Kofi Frimpong-Manson, Lida Khodavirdilou, Md Tareq Aziz, Jenny L. Wilkerson, Jonathan Thompson, Ulrich Bickel, Prasanth K. Chelikani, Ayman Farag, Mahmoud Salama Ahmed
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2025-09-01
Edice:	Pharmacological Research
Témata:	Metabolic syndrome Insulin resistance Obesity EphB tyrosine kinase Metabolism
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S1043661825003251
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!